Linde (LIN) Form 4 LINDE / Anne K Roby ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Roby Anne K

(Last) (First) (Middle)

C/O LINDE PLC

THE PRIESTLEY CENTRE, 10 PRIESTLEY ROAD

(Street)

GUILDFORD, SURREY X0 GU2 7XY

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Head of Global Functions Group

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2019

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	03/20/2019		M		13,195	A	$97.84	41,995.522	D
Ordinary Shares	03/20/2019		F		10,036(1)	D	$176.77	31,959.502	D
Ordinary Shares	03/20/2019		S		3,159	D	$176.77(2)	28,800.522	D
Ordinary Shares								1,529.357	I	401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Ristricted Stock Units	(3)	03/20/2019		A		2,330		(3)	(3)	Ordinary Shares	2,330	$0	2,330	D
Restricted Stock Units	$0(4)							(4)	(4)	Ordinary Shares	3,885		3,885	D
Restricted Stock Units	$0(5)							(5)	(5)	Ordinary Shares	4,328		4,328	D
Restricted Stock Units	$0(5)							(5)	(5)	Ordinary Shares	2,960		2,960	D
Stock Option (right to buy)	$176.63	03/20/2019		A		26,230		03/20/2020(6)	03/20/2029	Ordinary Shares	26,230	$0	26,230	D
Stock Option (right to buy)	$97.84	03/20/2019		M			13,195	02/22/2012	02/22/2021	Ordinary Shares	13,195	$0	0	D
Stock Option (right to buy)	$109.68							02/28/2013(7)	02/28/2022	Ordinary Shares	18,430		18,430	D
Stock Option (right to buy)	$110.58							02/26/2014(7)	02/26/2023	Ordinary Shares	15,790		15,790	D
Stock Option (right to buy)	$128.8							02/25/2015(7)	02/25/2024	Ordinary Shares	19,900		19,900	D
Stock Option (right to buy)	$128.38							02/24/2016(7)	02/24/2025	Ordinary Shares	26,490		26,490	D
Stock Option (right to buy)	$102.22							02/23/2017(8)	02/23/2026	Ordinary Shares	49,405		49,405	D
Stock Option (right to buy)	$118.71							02/28/2018(9)	02/28/2027	Ordinary Shares	39,585		39,585	D
Stock Option (right to buy)	$154							02/27/2019(10)	02/27/2028	Ordinary Shares	32,335		32,335	D
Deferred Stock Unit	(10)							(11)	(11)	Ordinary Shares	56.83		56.83	D

Explanation of Responses:

1. Shares withheld for taxes and to pay the option exercise price.

2. $176.77 was the average per share sale price. Actual per share prices ranged from $176.77 to $176.79 and will be provided upon the request of the SEC and any shareholder.

3. Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one-basis.

4. Restricted Stock units that will vest in full and payout on or about February 23, 2021 in Linde plc Ordinary Shares on a one-for-one basis.

5. Restricted Stock Units that will vest in full and payout on or about February 28, 2020 in Linde plc Ordinary Shares on a one-for-one basis.

6. This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.

7. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.

8. This option vests over three years in three consecutive equal annual installments beginning on February 23, 2017.

9. This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018.

10. Conversion to Linde plc ordinary shares is on a one-for-one basis.

11. Deferred stock units acquired under the Compensation Deferred Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for one basis in accordance with the Plan.

Remarks:

	Anthony M. Pepper, Attorney-in-Fact	03/22/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.